Jin, Qiao
Lau, Eric S. H.
Luk, Andrea O.
Tam, Claudia H. T.
Ozaki, Risa
Lim, Cadmon K. P.
Wu, Hongjiang
Chow, Elaine Y. K.
Kong, Alice P. S.
Lee, Heung Man
Fan, Baoqi
Ng, Alex C. W.
Jiang, Guozhi
Lee, Ka Fai
Siu, Shing Chung
Hui, Grace
Tsang, Chiu Chi
Lau, Kam Piu
Leung, Jenny Y.
Tsang, Man-wo
Cheung, Elaine Y. N.
Kam, Grace
Lau, Ip Tim
Li, June K.
Yeung, Vincent T.
Lau, Emmy
Lo, Stanley
Fung, Samuel
Cheng, Yuk Lun
Chow, Chun Chung
Yu, Weichuan
Tsui, Stephen K. W.
Huang, Yu
Lan, Hui-yao
Szeto, Cheuk Chun
So, Wing Yee
Jenkins, Alicia J.
Chan, Juliana C. N.
Ma, Ronald C. W.
,
Funding for this research was provided by:
the Research Grants Council of the Hong Kong Special Administrative Region (CU R4012-18)
the NSFC-NHMRC Joint Research Scheme (Ref. 81561128017)
Research Grants Council Theme-based Research Scheme (T12-402/13N)
a Croucher Foundation Senior Medical Research Fellowship, and Research Grants Council Senior Research Fellow (SRFS2021-4S04)
Article History
Received: 9 November 2022
Accepted: 13 December 2022
First Online: 31 December 2022
Declarations
:
: All participants provided written informed consent at the time of enrolment and the study was approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee, as well as the Clinical Research Ethics Committee of each participating hospital.
: Not applicable.
: JCNC received consultancy fees from Astra Zeneca, Bayer, Boehringer Ingelheim, Celltrion, MSD, Pfizer, Servier and Viatris Pharmaceutical, speaker fees from Astra Zeneca, Bayer, Boehringer Ingelheim, MSD, Merck, Sanofi and Servier and research grants through her institutions from Applied Therapeutics, Astra Zeneca, Hua Medicine, Lee Powder, Lilly, Merck and Servier. APSK received research grants from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Eli-Lilly, Kyowa Kirin, and Merck Serono, and honoraria for consultancy or giving lectures from Nestle, Novo Nordisk, Pfizer, and Sanofi. EYKC received speaker fees from Sanofi and Novartis, and institutional research funding from Sanofi, Medtronic Diabetes, and Powder Pharmaceuticals Inc. RCWM received research funding from AstraZeneca, Bayer, Merck Sharp & Dohme, Novo Nordisk, Pfizer, Roche Diagnostics and Tricida Inc. for carrying out clinical trials or studies, and from AstraZeneca, Bayer and Boehringer Ingelheim for speaker honoraria or consultancy in advisory boards. All proceeds have been donated to the Chinese University of Hong Kong to support diabetes research. The remaining authors declare that they have no relevant financial interests.